Dr. Michael P. Thomas

Stanley J. Chetcuti, M.D., is a Clinical Professor of Internal Medicine and the Eric J. Topol Collegiate Professor of Cardiovascular Medicine who serves as Director of the Cardiac Catheterization Laboratory and the Interventional Cardiology Fellowship Program. His research focuses on percutaneous circulatory support systems, novel treatment for acute coronary syndromes, and percutaneous management of patients with structural heart disease. Dr. Chetcuti is highly rated in 23 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Aortic Regurgitation, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Dr. Hitinder S. Gurm is an interventional cardiologist and is a Professor of Internal Medicine . He is currently serving as the interim Chief Medical Officer of the University of Michigan Health System. Dr. Gurm is a graduate of Christian Medical College, Ludhiana, India. He did his residency in Internal medicine followed by a fellowship in Cardiology and Interventional Cardiology at the Cleveland Clinic Foundation. His research interests include carotid interventions, contrast-induced nephropathy, quality improvement and outcomes assessment, and development of novel devices for endovascular interventions. He has published more than 250 original articles and book chapters and has been named as an inventor on 4 patents. He is the recipient of the Michigan Health & Hospital Association’s Patient Safety & Quality Leadership Award for 2016 and has been elected to the American Society for Clinical Investigation (ASCI). Dr. Gurm was selected as one of 50 experts leading the field of patient safety in 2018 by Becker Hospital Review. Dr. Gurm is highly rated in 16 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Atherosclerosis, Lithotripsy, and Percutaneous Coronary Intervention (PCI).

Dr. Grossman is a Professor of Internal Medicine in the Division of Cardiovascular Medicine at the University of Michigan and a staff cardiologist at the VA Ann Arbor. Director of the Blue Cross Blue Shield of Michigan Cardiovascular Consortium Peripheral Vascular Intervention (BMC2 PVI), and Co-director of the University of Michigan Cardiovascular Center Multidisciplinary Peripheral Arterial Disease Program. He completed his MD at the University of Nebraska, his residency at the University of California San Diego, where he also served as chief resident, and his cardiology and interventional cardiology fellowships at the University of Michigan. Dr. Grossman is an interventional cardiologist with clinical interest in catheter based treatment of coronary, peripheral arterial, structural heart and valvular heart disease. His academic interests are focused on quality improvement in management of peripheral arterial disease and therapeutic angiogenesis. Dr. Grossman is highly rated in 16 conditions, according to our data. His top areas of expertise are Aortic Valve Stenosis, Peripheral Artery Disease, Atherosclerosis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.